The pathophysiology of COVID-19-associated AKI is complex, and an increasing number of studies suggest that factors such as systemic inflammation and immune responses, activation of coagulation pathways, the renin–angiotensin system, and endothelial injury are involved in the process of renal damage that occurs in COVID-19 (9, 11, 12). This evidence concerns the gene REN and COVID-19.